Eisai Co., Ltd.: all 644 studies

Page 3 of 7. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)CompletedNCT00770510Phase 2/3Results posted
• Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00760084Phase 2Results posted
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17TerminatedNCT00754052Phase 3Results posted
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10TerminatedNCT00754013Phase 3Results posted
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerTerminatedNCT00738699Phase 2Results posted
• An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural MesotheliomaCompletedNCT00738582Phase 2Results posted
• Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresCompletedNCT00735397Phase 3Results posted
• Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh SystemCompletedNCT00706095Phase 1Results posted
• Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresCompletedNCT00700310Phase 3Results posted
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresCompletedNCT00699972Phase 3Results posted
• To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresCompletedNCT00699582Phase 3Results posted
• Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised EpilepsyTerminatedNCT00693017Phase 3Results posted
• Adjunctive Zonisamide in Primary Generalised Tonic Clonic SeizuresTerminatedNCT00692003Phase 3Results posted
• Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer TreatmentCompletedNCT00688376Phase 3Results posted
• Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled TrialTerminatedNCT00675025Phase 2Results posted
• Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658775Phase 3Results posted
• Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658632Phase 3Results posted
• Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)CompletedNCT00658528Phase 3Results posted
• Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003CompletedNCT00625443Phase 2Results posted
• A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)CompletedNCT00619099Phase 2Results posted
• BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity ManagementCompletedNCT00603902Phase 3Results posted
• BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes MellitusCompletedNCT00603291Phase 3Results posted
• A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy BodiesCompletedNCT00598650Phase 2Results posted
• Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)CompletedNCT00592904Phase 2/3Results posted
• Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)CompletedNCT00592774Phase 2Results posted
• The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living FacilityCompletedNCT00571064Phase 4Results posted
• An Efficacy Study of MORAb-009 in Subjects With Pancreatic CancerCompletedNCT00570713Phase 2Results posted
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down SyndromeCompletedNCT00570128Phase 2Results posted
• Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's DiseaseCompletedNCT00566501Phase 3Results posted
• Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECTTerminatedNCT00566462Phase 2Results posted
• Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)CompletedNCT00566254Phase 3Results posted
• A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)CompletedNCT00543855Phase 2Results posted
• Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain CancerCompletedNCT00525590Phase 2Results posted
• Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor FluctuationsTerminatedNCT00505622Phase 3Results posted
• An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic NeuropathyCompletedNCT00505284Phase 2/3Results posted
• Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT00478205Phase 3Results posted
• Neural Correlates In Mild Alzheimer's DiseaseCompletedNCT00477659Phase 4Results posted
• A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial EpilepsyCompletedNCT00477295Phase 3Results posted
• Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresTerminatedNCT00448539Phase 3Results posted
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00441090Phase 2Results posted
• A Study of E2007 In Patients With Parkinson's DiseaseTerminatedNCT00427011Phase 2Results posted
• Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial SeizuresCompletedNCT00416195Phase 2Results posted
• E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue SarcomaCompletedNCT00413192Phase 2Results posted
• BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity ManagementCompletedNCT00395135Phase 3Results posted
• E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00388726Phase 3Results posted
• The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's DiseaseCompletedNCT00381381Phase 4Results posted
• 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial SeizuresCompletedNCT00368472Phase 2Results posted
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT00368108Phase 3Results posted
• A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT00360412Phase 3Results posted
• Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT00360308Phase 3Results posted
• Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)CompletedNCT00358644Phase 2Results posted
• E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesCompletedNCT00337103Phase 3Results posted
• Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial SeizuresCompletedNCT00334958Phase 3Results posted
• Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial SeizuresCompletedNCT00327717Phase 3Results posted
• A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.CompletedNCT00327392Phase 2/3Results posted
• Phase I Clinical Study of E7389CompletedNCT00326950Phase 1Results posted
• Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyCompletedNCT00318370Phase 2Results posted
• A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized SeizuresCompletedNCT00292461Phase 3Results posted
• An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid TumorsCompletedNCT00280397Phase 1Results posted
• An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian SubjectsCompletedNCT00280384Phase 2Results posted
• Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior ChemotherapyCompletedNCT00278993Phase 2Results posted
• A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid TumorsCompletedNCT00268905Phase 1Results posted
• Trial of Decitabine in Patients With Acute Myeloid LeukemiaCompletedNCT00260832Phase 3Results posted
• A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic SyndromesCompletedNCT00260065Phase 2Results posted
• A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and CapecitabineCompletedNCT00246090Phase 2Results posted
• E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent SufferersCompletedNCT00236197Phase 3Results posted
• E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent SufferersCompletedNCT00236184Phase 3Results posted
• A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell LymphomaCompletedNCT00211185Phase 2Results posted
• A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical ProceduresTerminatedNCT00209560Phase 3Results posted
• Maintenance Intermittent Therapy for Symptomatic GERD PatientsCompletedNCT00165841Phase 2Results posted
• A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor FluctuationsCompletedNCT00165789Phase 2Results posted
• Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic TorticollisCompletedNCT00165776Phase 2Results posted
• Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis WomenCompletedNCT00165698Phase 3Results posted
• A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux DiseaseCompletedNCT00165672Phase 3Results posted
• A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux DiseaseCompletedNCT00165646Phase 3Results posted
• Efficacy and Safety Study of E2007 in Migraine ProphylaxisCompletedNCT00154063Phase 2Results posted
• Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With RabeprazoleCompletedNCT00132496Phase 2Results posted
• An Open Label Dose Escalation Study Of E7080CompletedNCT00121719Phase 1Results posted
• Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet ChemotherapyCompletedNCT00100932Phase 2Results posted
• A Study of E7389 in Advanced/Metastatic Breast Cancer PatientsCompletedNCT00097721Phase 2Results posted
• Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid TumorsCompletedNCT00069277Phase 1Results posted
• Study of E7389 in Patients With Advanced Solid TumorsCompletedNCT00069264Phase 1Results posted
• Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)CompletedNCT00051025Phase 2Results posted
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050960Phase 3Results posted
• Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)Active, not recruitingNCT07849660
• A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's DiseaseActive, not recruitingNCT07723950
• A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male ParticipantsCompletedNCT07308236Phase 1
• A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical PracticeActive, not recruitingNCT06964113Phase 4
• A Study of Oral E1018 in Healthy Adult ParticipantsActive, not recruitingNCT06854042Phase 1
• A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control PopulationActive, not recruitingNCT06744673
• A Study of Filgotinib in Korean Participants With Rheumatoid ArthritisCompletedNCT06625242Phase 4
• A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseActive, not recruitingNCT06602258Phase 2
• A Study of E2086 in Healthy Adult ParticipantsCompletedNCT06481488Phase 1
• A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1CompletedNCT06462404Phase 1
• A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast CancerCompletedNCT06188559Phase 2
• A Community-Based Screening Program to Identify Participants at High Risk for Amyloid PathologyActive, not recruitingNCT06043700
• A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly ParticipantsCompletedNCT05745207Phase 1
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy ParticipantsCompletedNCT05726851Phase 1
• A Study Based on the French National Health Insurance Database in Participants With Psychotic DisordersCompletedNCT05633108
• A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male ParticipantsCompletedNCT05607537Phase 1

← Eisai Co., Ltd. overview and focus areas